Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain.
Update in vitamin D and multiple sclerosis.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
A novel activity for fungal nitronate monooxygenase: Detoxification of the metabolic inhibitor propionate-3-nitronate.
The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions.
[A review of multiple sclerosis (1). Presentation of a case.]
The risk of cancer from azathioprine as a treatment for multiple sclerosis.
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
Human Umbilical Tissue-Derived Cells Promote Synapse Formation and Neurite Outgrowth via Thrombospondin Family Proteins.
The multiple sclerosis self-management scale: clinicometric testing.
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury.
Neurological disorders in the Global Burden of Disease 2010 study.
Validity of Maximal Exercise Testing in Patients With Low to Moderate Multiple Sclerosis.
The RESTORE trial: What did we learn about multiple sclerosis?
APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction.
Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample.
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Blood cells and endothelial barrier function.
Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial.
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
Pages
« first
‹ previous
…
410
411
412
413
414
415
416
417
418
…
next ›
last »